Q32 Bio Inc. Faces Delisting or Listing Transfer
Ticker: QTTB · Form: 8-K · Filed: May 23, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rule, corporate-action
TL;DR
Q32 Bio is on the chopping block for its stock exchange listing.
AI Summary
Q32 Bio Inc. filed an 8-K on May 23, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The earliest event reported was on May 19, 2025. The company was formerly known as Homology Medicines, Inc. until December 28, 2015.
Why It Matters
This filing indicates potential issues with Q32 Bio Inc.'s continued listing on its current exchange, which could impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall financial stability.
Key Players & Entities
- Q32 Bio Inc. (company) — Registrant
- May 19, 2025 (date) — Earliest event reported
- May 23, 2025 (date) — Filing date
- Homology Medicines, Inc. (company) — Former company name
- December 28, 2015 (date) — Date of name change
FAQ
What specific rule or standard has Q32 Bio Inc. failed to satisfy, leading to this notice?
The filing does not specify the exact rule or standard that Q32 Bio Inc. has failed to satisfy, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard'.
What is the nature of the 'Transfer of Listing' mentioned in the filing?
The filing indicates a 'Transfer of Listing' alongside the notice of potential delisting, but does not provide details on the destination exchange or the process.
When was the earliest event reported that triggered this 8-K filing?
The earliest event reported was on May 19, 2025.
What was Q32 Bio Inc.'s former name, and when did the name change occur?
Q32 Bio Inc.'s former name was Homology Medicines, Inc., and the date of the name change was December 28, 2015.
What is the principal executive office address for Q32 Bio Inc.?
The principal executive offices are located at 830 Winter Street, Waltham, Massachusetts, 02451.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Q32 Bio Inc. (QTTB).